相关实验视频
Updated: Jul 5, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
CDC123通过调节CDKAL1促进肝细胞癌的恶性进展
Yong Wang1, HongTao Pan1, XuanKun Gong2
1The Clinical College, Anhui No.2 Provincial People's Hospital, Anhui Medical University, Hefei 230041, Anhui, China.
细胞增殖蛋白123 (CDC123) 的高表达与肝细胞癌 (HCC) 的预后不佳相关. CDC123 Knockdown 抑制了 HCC 细胞的生长,这表明它是.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 细胞增殖蛋白123 (CDC123) 涉及到真核细胞的翻译过程.
- CDC123是乳腺癌中的候选瘤基因,但其在肝细胞癌 (HCC) 中的作用尚不清楚.
研究的目的:
- 研究CDC123在HCC中的表达和预后意义.
- 阐明CDC123在HCC进展中的作用及其潜在的分子机制.
主要方法:
- 使用TCGA数据库用于CDC123RNA-seq和临床数据.
- 进行了卡普兰-梅尔和多变量考克斯分析以评估预后.
- 在HCC细胞系中进行了CDC123的淘汰实验.
主要成果:
- 在HCC组织中,CDC123的调控显著上升.
- 高的CDC123表达与较差的HCC患者预后有关,并被确定为独立的预后因素.
- 疾病预防控制中心123击倒抑制了HCC细胞的增殖,入侵和迁移.
- CDC123与CDKAL1共同表达,在CDC123沉默时CDKAL1水平下降.
结论:
- CDC123是一种潜在的致癌基因,可以促进HCC的进展.
- CDC123可能通过调节CDKAL1.1来发挥其致癌作用.
- CDC123代表了肝细胞癌的一个有前途的治疗点.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
相关概念视频
Inhibition of Cdk Activity
Positive Regulator Molecules
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
Anaphase Promoting Complex